Accession PRJCA016749
Title Single-dose, randomized, open-label, two-cycle, cross-over relative bioavailability study of SHR2554 tablets with different processes in healthy subjects
Relevance Medical
Data types clinical,image,Metabolic,Biomarker data
Organisms Homo sapiens
Description Single-dose, randomized, open-label, two-cycle, cross-over relative bioavailability study of SHR2554 tablets with different processes in healthy subjects
Sample scope Multiisolate
Release date 2023-05-05
Grants
Agency program Grant ID Grant title
NA NA
Submitter wanqiu liang (wanqiu.liang@hengrui.com)
Organization Jiangsu Hengrui Pharmaceutical Co. LTD
Submission date 2023-05-05

Project Data

Resource name Description